FDA 483 - US Infusion, Inc. - March 06, 2023

US Infusion, Inc. in South Miami, FL, a specification developer, was inspected by the FDA and received two observations. The inspection revealed deficiencies in establishing adequate quality agreements with contract manufacturers and in documenting corrective and preventive actions for product complaints, specifically regarding leaking IV administration sets.